Click for best price
Nasal Antihistamines Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Nasal Antihistamines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nasal Antihistamines. This report contains market size and forecasts of Nasal Antihistamines in global, including the following market information:
Global Nasal Antihistamines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Nasal Antihistamines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Sprays Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Nasal Antihistamines include Bayer Healthcare, Novartis, Merck& Co inc, Zicam LLC, F.Hoffman La Roche, Ache Laboratories, GlaxoSmithKline, ARIUS FORMULATIONS PVT LTD and Renatus, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nasal Antihistamines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nasal Antihistamines Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Nasal Antihistamines Market Segment Percentages, by Type, 2022 (%)
Sprays
Drops
Gels
Global Nasal Antihistamines Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Nasal Antihistamines Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Pharmacy
Homecare Setting
Global Nasal Antihistamines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Nasal Antihistamines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nasal Antihistamines revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Nasal Antihistamines revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer Healthcare
Novartis
Merck& Co inc
Zicam LLC
F.Hoffman La Roche
Ache Laboratories
GlaxoSmithKline
ARIUS FORMULATIONS PVT LTD
Renatus
Aurena
Cipla
Allergan
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nasal Antihistamines, market overview.
Chapter 2: Global Nasal Antihistamines market size in revenue.
Chapter 3: Detailed analysis of Nasal Antihistamines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nasal Antihistamines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Report Attributes |
Report Details |
Report Title |
Nasal Antihistamines Market, Global Outlook and Forecast 2023-2032 |
Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
Base Year |
2022 |
Forecast Year |
2030 |
Number of Pages |
64 Pages |
Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Nasal Antihistamines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nasal Antihistamines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nasal Antihistamines Overall Market Size
2.1 Global Nasal Antihistamines Market Size: 2022 VS 2032
2.2 Global Nasal Antihistamines Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nasal Antihistamines Players in Global Market
3.2 Top Global Nasal Antihistamines Companies Ranked by Revenue
3.3 Global Nasal Antihistamines Revenue by Companies
3.4 Top 3 and Top 5 Nasal Antihistamines Companies in Global Market, by Revenue in 2022
3.5 Global Companies Nasal Antihistamines Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nasal Antihistamines Players in Global Market
3.6.1 List of Global Tier 1 Nasal Antihistamines Companies
3.6.2 List of Global Tier 2 and Tier 3 Nasal Antihistamines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Nasal Antihistamines Market Size Markets, 2022 & 2032
4.1.2 Sprays
4.1.3 Drops
4.1.4 Gels
4.2 By Type - Global Nasal Antihistamines Revenue & Forecasts
4.2.1 By Type - Global Nasal Antihistamines Revenue, 2018-2023
4.2.2 By Type - Global Nasal Antihistamines Revenue, 2024-2032
4.2.3 By Type - Global Nasal Antihistamines Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nasal Antihistamines Market Size, 2022 & 2032
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Pharmacy
5.1.5 Homecare Setting
5.2 By Application - Global Nasal Antihistamines Revenue & Forecasts
5.2.1 By Application - Global Nasal Antihistamines Revenue, 2018-2023
5.2.2 By Application - Global Nasal Antihistamines Revenue, 2024-2032
5.2.3 By Application - Global Nasal Antihistamines Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Nasal Antihistamines Market Size, 2022 & 2032
6.2 By Region - Global Nasal Antihistamines Revenue & Forecasts
6.2.1 By Region - Global Nasal Antihistamines Revenue, 2018-2023
6.2.2 By Region - Global Nasal Antihistamines Revenue, 2024-2032
6.2.3 By Region - Global Nasal Antihistamines Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Nasal Antihistamines Revenue, 2018-2032
6.3.2 US Nasal Antihistamines Market Size, 2018-2032
6.3.3 Canada Nasal Antihistamines Market Size, 2018-2032
6.3.4 Mexico Nasal Antihistamines Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Nasal Antihistamines Revenue, 2018-2032
6.4.2 Germany Nasal Antihistamines Market Size, 2018-2032
6.4.3 France Nasal Antihistamines Market Size, 2018-2032
6.4.4 U.K. Nasal Antihistamines Market Size, 2018-2032
6.4.5 Italy Nasal Antihistamines Market Size, 2018-2032
6.4.6 Russia Nasal Antihistamines Market Size, 2018-2032
6.4.7 Nordic Countries Nasal Antihistamines Market Size, 2018-2032
6.4.8 Benelux Nasal Antihistamines Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Nasal Antihistamines Revenue, 2018-2032
6.5.2 China Nasal Antihistamines Market Size, 2018-2032
6.5.3 Japan Nasal Antihistamines Market Size, 2018-2032
6.5.4 South Korea Nasal Antihistamines Market Size, 2018-2032
6.5.5 Southeast Asia Nasal Antihistamines Market Size, 2018-2032
6.5.6 India Nasal Antihistamines Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Nasal Antihistamines Revenue, 2018-2032
6.6.2 Brazil Nasal Antihistamines Market Size, 2018-2032
6.6.3 Argentina Nasal Antihistamines Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nasal Antihistamines Revenue, 2018-2032
6.7.2 Turkey Nasal Antihistamines Market Size, 2018-2032
6.7.3 Israel Nasal Antihistamines Market Size, 2018-2032
6.7.4 Saudi Arabia Nasal Antihistamines Market Size, 2018-2032
6.7.5 UAE Nasal Antihistamines Market Size, 2018-2032
7 Nasal Antihistamines Companies Profiles
7.1 Bayer Healthcare
7.1.1 Bayer Healthcare Company Summary
7.1.2 Bayer Healthcare Business Overview
7.1.3 Bayer Healthcare Nasal Antihistamines Major Product Offerings
7.1.4 Bayer Healthcare Nasal Antihistamines Revenue in Global Market (2018-2023)
7.1.5 Bayer Healthcare Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Nasal Antihistamines Major Product Offerings
7.2.4 Novartis Nasal Antihistamines Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Merck& Co inc
7.3.1 Merck& Co inc Company Summary
7.3.2 Merck& Co inc Business Overview
7.3.3 Merck& Co inc Nasal Antihistamines Major Product Offerings
7.3.4 Merck& Co inc Nasal Antihistamines Revenue in Global Market (2018-2023)
7.3.5 Merck& Co inc Key News & Latest Developments
7.4 Zicam LLC
7.4.1 Zicam LLC Company Summary
7.4.2 Zicam LLC Business Overview
7.4.3 Zicam LLC Nasal Antihistamines Major Product Offerings
7.4.4 Zicam LLC Nasal Antihistamines Revenue in Global Market (2018-2023)
7.4.5 Zicam LLC Key News & Latest Developments
7.5 F.Hoffman La Roche
7.5.1 F.Hoffman La Roche Company Summary
7.5.2 F.Hoffman La Roche Business Overview
7.5.3 F.Hoffman La Roche Nasal Antihistamines Major Product Offerings
7.5.4 F.Hoffman La Roche Nasal Antihistamines Revenue in Global Market (2018-2023)
7.5.5 F.Hoffman La Roche Key News & Latest Developments
7.6 Ache Laboratories
7.6.1 Ache Laboratories Company Summary
7.6.2 Ache Laboratories Business Overview
7.6.3 Ache Laboratories Nasal Antihistamines Major Product Offerings
7.6.4 Ache Laboratories Nasal Antihistamines Revenue in Global Market (2018-2023)
7.6.5 Ache Laboratories Key News & Latest Developments
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Company Summary
7.7.2 GlaxoSmithKline Business Overview
7.7.3 GlaxoSmithKline Nasal Antihistamines Major Product Offerings
7.7.4 GlaxoSmithKline Nasal Antihistamines Revenue in Global Market (2018-2023)
7.7.5 GlaxoSmithKline Key News & Latest Developments
7.8 ARIUS FORMULATIONS PVT LTD
7.8.1 ARIUS FORMULATIONS PVT LTD Company Summary
7.8.2 ARIUS FORMULATIONS PVT LTD Business Overview
7.8.3 ARIUS FORMULATIONS PVT LTD Nasal Antihistamines Major Product Offerings
7.8.4 ARIUS FORMULATIONS PVT LTD Nasal Antihistamines Revenue in Global Market (2018-2023)
7.8.5 ARIUS FORMULATIONS PVT LTD Key News & Latest Developments
7.9 Renatus
7.9.1 Renatus Company Summary
7.9.2 Renatus Business Overview
7.9.3 Renatus Nasal Antihistamines Major Product Offerings
7.9.4 Renatus Nasal Antihistamines Revenue in Global Market (2018-2023)
7.9.5 Renatus Key News & Latest Developments
7.10 Aurena
7.10.1 Aurena Company Summary
7.10.2 Aurena Business Overview
7.10.3 Aurena Nasal Antihistamines Major Product Offerings
7.10.4 Aurena Nasal Antihistamines Revenue in Global Market (2018-2023)
7.10.5 Aurena Key News & Latest Developments
7.11 Cipla
7.11.1 Cipla Company Summary
7.11.2 Cipla Business Overview
7.11.3 Cipla Nasal Antihistamines Major Product Offerings
7.11.4 Cipla Nasal Antihistamines Revenue in Global Market (2018-2023)
7.11.5 Cipla Key News & Latest Developments
7.12 Allergan
7.12.1 Allergan Company Summary
7.12.2 Allergan Business Overview
7.12.3 Allergan Nasal Antihistamines Major Product Offerings
7.12.4 Allergan Nasal Antihistamines Revenue in Global Market (2018-2023)
7.12.5 Allergan Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Nasal Antihistamines Market Opportunities & Trends in Global Market
Table 2. Nasal Antihistamines Market Drivers in Global Market
Table 3. Nasal Antihistamines Market Restraints in Global Market
Table 4. Key Players of Nasal Antihistamines in Global Market
Table 5. Top Nasal Antihistamines Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Nasal Antihistamines Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Nasal Antihistamines Revenue Share by Companies, 2018-2023
Table 8. Global Companies Nasal Antihistamines Product Type
Table 9. List of Global Tier 1 Nasal Antihistamines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nasal Antihistamines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Nasal Antihistamines Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Nasal Antihistamines Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Nasal Antihistamines Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Nasal Antihistamines Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Nasal Antihistamines Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Nasal Antihistamines Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Nasal Antihistamines Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Nasal Antihistamines Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Nasal Antihistamines Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Nasal Antihistamines Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Nasal Antihistamines Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Nasal Antihistamines Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Nasal Antihistamines Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Nasal Antihistamines Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Nasal Antihistamines Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Nasal Antihistamines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Nasal Antihistamines Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Nasal Antihistamines Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Nasal Antihistamines Revenue, (US$, Mn), 2024-2032
Table 30. Bayer Healthcare Company Summary
Table 31. Bayer Healthcare Nasal Antihistamines Product Offerings
Table 32. Bayer Healthcare Nasal Antihistamines Revenue (US$, Mn) & (2018-2023)
Table 33. Bayer Healthcare Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Nasal Antihistamines Product Offerings
Table 36. Novartis Nasal Antihistamines Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Merck& Co inc Company Summary
Table 39. Merck& Co inc Nasal Antihistamines Product Offerings
Table 40. Merck& Co inc Nasal Antihistamines Revenue (US$, Mn) & (2018-2023)
Table 41. Merck& Co inc Key News & Latest Developments
Table 42. Zicam LLC Company Summary
Table 43. Zicam LLC Nasal Antihistamines Product Offerings
Table 44. Zicam LLC Nasal Antihistamines Revenue (US$, Mn) & (2018-2023)
Table 45. Zicam LLC Key News & Latest Developments
Table 46. F.Hoffman La Roche Company Summary
Table 47. F.Hoffman La Roche Nasal Antihistamines Product Offerings
Table 48. F.Hoffman La Roche Nasal Antihistamines Revenue (US$, Mn) & (2018-2023)
Table 49. F.Hoffman La Roche Key News & Latest Developments
Table 50. Ache Laboratories Company Summary
Table 51. Ache Laboratories Nasal Antihistamines Product Offerings
Table 52. Ache Laboratories Nasal Antihistamines Revenue (US$, Mn) & (2018-2023)
Table 53. Ache Laboratories Key News & Latest Developments
Table 54. GlaxoSmithKline Company Summary
Table 55. GlaxoSmithKline Nasal Antihistamines Product Offerings
Table 56. GlaxoSmithKline Nasal Antihistamines Revenue (US$, Mn) & (2018-2023)
Table 57. GlaxoSmithKline Key News & Latest Developments
Table 58. ARIUS FORMULATIONS PVT LTD Company Summary
Table 59. ARIUS FORMULATIONS PVT LTD Nasal Antihistamines Product Offerings
Table 60. ARIUS FORMULATIONS PVT LTD Nasal Antihistamines Revenue (US$, Mn) & (2018-2023)
Table 61. ARIUS FORMULATIONS PVT LTD Key News & Latest Developments
Table 62. Renatus Company Summary
Table 63. Renatus Nasal Antihistamines Product Offerings
Table 64. Renatus Nasal Antihistamines Revenue (US$, Mn) & (2018-2023)
Table 65. Renatus Key News & Latest Developments
Table 66. Aurena Company Summary
Table 67. Aurena Nasal Antihistamines Product Offerings
Table 68. Aurena Nasal Antihistamines Revenue (US$, Mn) & (2018-2023)
Table 69. Aurena Key News & Latest Developments
Table 70. Cipla Company Summary
Table 71. Cipla Nasal Antihistamines Product Offerings
Table 72. Cipla Nasal Antihistamines Revenue (US$, Mn) & (2018-2023)
Table 73. Cipla Key News & Latest Developments
Table 74. Allergan Company Summary
Table 75. Allergan Nasal Antihistamines Product Offerings
Table 76. Allergan Nasal Antihistamines Revenue (US$, Mn) & (2018-2023)
Table 77. Allergan Key News & Latest Developments
List of Figures
Figure 1. Nasal Antihistamines Segment by Type in 2022
Figure 2. Nasal Antihistamines Segment by Application in 2022
Figure 3. Global Nasal Antihistamines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Nasal Antihistamines Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Nasal Antihistamines Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Nasal Antihistamines Revenue in 2022
Figure 8. By Type - Global Nasal Antihistamines Revenue Market Share, 2018-2032
Figure 9. By Application - Global Nasal Antihistamines Revenue Market Share, 2018-2032
Figure 10. By Type - Global Nasal Antihistamines Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Nasal Antihistamines Revenue Market Share, 2018-2032
Figure 12. By Application - Global Nasal Antihistamines Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Nasal Antihistamines Revenue Market Share, 2018-2032
Figure 14. By Region - Global Nasal Antihistamines Revenue Market Share, 2018-2032
Figure 15. By Country - North America Nasal Antihistamines Revenue Market Share, 2018-2032
Figure 16. US Nasal Antihistamines Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Nasal Antihistamines Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Nasal Antihistamines Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Nasal Antihistamines Revenue Market Share, 2018-2032
Figure 20. Germany Nasal Antihistamines Revenue, (US$, Mn), 2018-2032
Figure 21. France Nasal Antihistamines Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Nasal Antihistamines Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Nasal Antihistamines Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Nasal Antihistamines Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Nasal Antihistamines Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Nasal Antihistamines Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Nasal Antihistamines Revenue Market Share, 2018-2032
Figure 28. China Nasal Antihistamines Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Nasal Antihistamines Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Nasal Antihistamines Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Nasal Antihistamines Revenue, (US$, Mn), 2018-2032
Figure 32. India Nasal Antihistamines Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Nasal Antihistamines Revenue Market Share, 2018-2032
Figure 34. Brazil Nasal Antihistamines Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Nasal Antihistamines Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Nasal Antihistamines Revenue Market Share, 2018-2032
Figure 37. Turkey Nasal Antihistamines Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Nasal Antihistamines Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Nasal Antihistamines Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Nasal Antihistamines Revenue, (US$, Mn), 2018-2032
Figure 41. Bayer Healthcare Nasal Antihistamines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Nasal Antihistamines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck& Co inc Nasal Antihistamines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Zicam LLC Nasal Antihistamines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. F.Hoffman La Roche Nasal Antihistamines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Ache Laboratories Nasal Antihistamines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. GlaxoSmithKline Nasal Antihistamines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. ARIUS FORMULATIONS PVT LTD Nasal Antihistamines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Renatus Nasal Antihistamines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Aurena Nasal Antihistamines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Cipla Nasal Antihistamines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Allergan Nasal Antihistamines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)